## Review setup
- **Input scope** Abstract only
- **Assessment boundary** Claims and evidence presented in the abstract; no access to full text, figures, tables, or supplementary materials
- **Shared manuscript claim summary** The authors combine computational domain prediction, electrostatic surface analysis, and in vivo localization to propose new structural domains in CeSPD-2, identify a basic region in the ASH domain, and group ASH, PapD, Usher chaperone, and MSP domains into a superfold within the Immunoglobulin superfamily, with the aim of informing future mechanistic studies.
- **Visible evidence base** Abstract text only; no figures, tables, methods, or data files provided
- **Missing materials affecting confidence** Full manuscript, all figures and tables, methods details, sequence alignments, prediction scores, localization images, and any statistical analyses

## Reviewer
- **Overall assessment** The abstract presents a plausible and potentially useful bioinformatics-driven exploration of SPD-2 structure-function relationships, with a modest in vivo localization component. However, the evidence base available for review is limited to the abstract, which prevents verification of the central claims. The novelty is moderate, as the identification of new domains and a superfold grouping is based entirely on computational prediction without experimental validation of function. The in vivo data appear preliminary and do not directly test the mechanistic hypotheses raised by the computational findings. The abstract is readable and logically organized, but several claims are stated with confidence that exceeds what the described evidence can support.
- **Who would be interested in the results, and why** Researchers studying centrosome biology, microtubule organization, and cell division, particularly those focused on C. elegans as a model system. Structural biologists interested in domain classification and superfold relationships within the Immunoglobulin superfamily may also find the computational grouping of interest. The work could inform hypothesis generation for experimental studies on SPD-2 and its human homolog CEP-192, which is relevant to cancer and ciliopathy research.
- **Major strengths** The abstract clearly states the biological importance of SPD-2 and the gap in mechanistic understanding. The combination of multiple computational tools (domain prediction, disorder prediction, electrostatic mapping) with a targeted in vivo localization experiment is a reasonable strategy. The identification of a basic region overlapping with predicted interaction residues in the ASH domain is a specific and testable finding. The proposed superfold grouping is a potentially interesting structural insight.
- **Major Concerns** The abstract does not provide sufficient detail to evaluate the robustness of the domain predictions, the significance of the electrostatic findings, or the quality of the localization data. The in vivo experiment is limited to localization and does not test function, so the claim of "mechanistic insight" is overstated. The superfold grouping is presented as a conclusion but appears to be a bioinformatic inference without experimental or high-resolution structural support.
- **Minor Comments** The abstract is dense with abbreviations, which may hinder readability for nonspecialists. The relationship between the predicted GEF, Ig-like, and PDZ-like domains and known SPD-2 functions is not explained. The statement that the basic region "overlaps with most of the residues predicted to be involved in protein-protein interactions" lacks quantitative context. The abstract would benefit from a clearer statement of what is novel versus confirmatory.
- **Technical failings that need to be addressed before the case is established** The abstract does not provide evidence that the computational predictions are validated by any experimental or structural data. The in vivo localization of ASH::GFP to centrosomes and microtubules is consistent with known SPD-2 localization and does not demonstrate a new function or mechanism. The superfold grouping is presented without supporting phylogenetic or structural evidence.
- **Assessment against Nature-style criteria** Originality: Moderate. The approach is not novel, and the findings are largely predictive. Scientific importance: Moderate. The work addresses a relevant protein but does not yet provide mechanistic insight beyond localization. Interdisciplinary readership: Limited. The abstract is primarily of interest to centrosome and structural biology specialists. Technical soundness: Not assessable from the abstract alone; prediction methods and thresholds are not described. Readability for nonspecialists: Acceptable but hindered by heavy abbreviation use and lack of context for the predicted domains.
- **Recommendation posture** Currently not established from the provided evidence. The abstract suggests a potentially useful resource for hypothesis generation, but the claims of mechanistic insight and superfold classification require additional experimental or structural validation that is not visible in the abstract.

### Major Concerns

- **Concern ID** R1-M1
- **Severity** Major
- **Blocking** Yes
- **Axis** Evidence sufficiency
- **Claim pointer** The abstract claims that the combined approach "provides mechanistic insight into its functional diversity" and that the identified domains and basic region "may shed mechanistic light on its function."
- **Evidence pointer** Abstract, Results section not provided
- **Concern** The only in vivo experiment described is localization of ASH::GFP to centrosomes and microtubules. Localization alone does not constitute mechanistic insight into how SPD-2 regulates centrosome maturation, centriole duplication, or spindle assembly. No functional assays, mutant phenotypes, or interaction data are described.
- **Why it matters** The title and abstract promise mechanistic understanding, but the visible evidence supports only a descriptive structural prediction and a localization pattern. Overstating the conclusions could mislead readers about the strength of the findings.
- **Resolution test** Provide functional experiments such as rescue assays with domain-deletion mutants, RNAi-based knockdown with domain-specific rescue constructs, or protein interaction assays that link the predicted domains to specific SPD-2 activities.

- **Concern ID** R1-M2
- **Severity** Major
- **Blocking** Yes
- **Axis** Technical validation
- **Claim pointer** The abstract states that domain prediction "corroborated and refined previously identified coiled-coils and ASH domains and identified new domains: a GEF domain, an Ig-like domain, and a PDZ-like domain."
- **Evidence pointer** Abstract, Methods not provided
- **Concern** No details are given on the prediction algorithms, confidence scores, sequence boundaries, or comparison with existing annotations. The identification of a GEF domain in SPD-2 is surprising given the protein's known role as a scaffold, and this claim requires strong bioinformatic support and ideally experimental validation.
- **Why it matters** Domain predictions are hypothesis-generating, not confirmatory. Without transparency on the methods and thresholds, the reliability of these new domain assignments cannot be assessed, and the risk of false positives is nontrivial.
- **Resolution test** Provide the prediction scores, multiple sequence alignments, and structural models for each new domain. Ideally, validate at least one new domain functionally or structurally.

- **Concern ID** R1-M3
- **Severity** Major
- **Blocking** Yes
- **Axis** Claim support
- **Claim pointer** The abstract claims that "ASH domains, PapD, Usher chaperone domains, and Major Sperm Protein (MSP) domains" form "a single superfold within the larger Immunoglobulin superfamily."
- **Evidence pointer** Abstract, Results section not provided
- **Concern** This is a strong evolutionary and structural claim. The abstract provides no phylogenetic analysis, structural comparisons, or fold recognition data to support this grouping. The relationship between ASH and MSP domains has been suggested before, but the inclusion of PapD and Usher chaperones as a unified superfold requires substantial evidence.
- **Why it matters** If correct, this grouping could have broad implications for understanding domain evolution and function. If incorrect or weakly supported, it could misdirect future research and undermine the credibility of the paper.
- **Resolution test** Provide structural alignments, fold recognition scores, and a phylogenetic tree or similarity matrix that quantitatively supports the superfold grouping. Ideally, include a comparison with known Ig superfamily members.

- **Concern ID** R1-M4
- **Severity** Major
- **Blocking** No
- **Axis** Interpretive clarity
- **Claim pointer** The abstract states that "a large basic region unique to the ASH domain of CeSPD-2" overlaps with "most of the residues predicted to be involved in protein-protein interactions."
- **Evidence pointer** Abstract, Figure not provided
- **Concern** The functional significance of this basic region is not explained. It is unclear whether this region is predicted to bind a specific partner, mediate membrane association, or contribute to microtubule binding. The overlap with interaction residues is stated but not interpreted in the context of SPD-2 function.
- **Why it matters** The basic region is presented as a key finding, but without a hypothesis about its role, the observation remains descriptive and does not advance mechanistic understanding.
- **Resolution test** Provide a testable hypothesis for the basic region's function, supported by mutagenesis or binding experiments, or at least a detailed comparison with known basic patches in other centrosomal proteins.

### Minor Comments

- **Concern ID** R1-m1
- **Severity** Minor
- **Axis** Readability
- **Affected element** Abstract text
- **Evidence pointer** Abstract, Abbreviations list
- **Issue** The abstract uses a large number of abbreviations, some of which are not standard for a broad audience, making the text difficult to follow.
- **Required correction** Reduce abbreviation use in the abstract or spell out key terms at first mention, even if they are defined in the abbreviation list.

- **Concern ID** R1-m2
- **Severity** Minor
- **Axis** Contextualization
- **Affected element** Introduction of new domains
- **Evidence pointer** Abstract, Results section not provided
- **Issue** The abstract does not explain how the newly predicted GEF, Ig-like, and PDZ-like domains might relate to known SPD-2 functions or to the functions of CEP-192 in humans.
- **Required correction** Add a sentence or two in the abstract or introduction that places these new domains in the context of known SPD-2/CEP-192 biology.

- **Concern ID** R1-m3
- **Severity** Minor
- **Axis** Quantitative detail
- **Affected element** Basic region overlap claim
- **Evidence pointer** Abstract, Figure not provided
- **Issue** The claim that the basic region overlaps with "most" of the predicted interaction residues is vague without a percentage or count.
- **Required correction** Provide a quantitative measure, such as the fraction of predicted interaction residues within the basic region, in the abstract or results.

- **Concern ID** R1-m4
- **Severity** Minor
- **Axis** Scope clarity
- **Affected element** Study purpose
- **Evidence pointer** Abstract, final sentence
- **Issue** The final sentence states the study "lays the groundwork" for future experiments, which is appropriate, but the abstract's title and earlier phrasing imply more direct mechanistic insight.
- **Required correction** Align the language in the title and abstract with the hypothesis-generating scope of the study.

## Risk / unsupported claims
- The claim of "mechanistic insight into its functional diversity" is unsupported by the visible evidence, which includes only localization data.
- The identification of new domains (GEF, Ig-like, PDZ-like) is unverifiable without prediction details and is presented as established rather than predicted.
- The superfold grouping of ASH, PapD, Usher chaperone, and MSP domains is unsupported by any visible structural or phylogenetic evidence.
- The functional relevance of the basic region in the ASH domain is not established, and its overlap with predicted interaction residues is stated without quantitative support.
- The in vivo localization of ASH::GFP is consistent with known SPD-2 localization and does not provide new functional information.